In vitro (human serum) · PMID 12942748
Effect of the peptide bioregulators livagen and epitalon on enkephalin-degrading enzymes in human serum — VialBase Research
Shows Livagen activity on serum peptidases; mechanistic breadth beyond chromatin.
Last updated · 2003 · Kost NV et al. · Izv Akad Nauk Ser Biol
Key findings
- Livagen (with Epitalon) influenced enkephalin-degrading enzyme activity in human serum
- Indicates broader peptidase-regulatory effects of the bioregulators
Livagen/Epitalon and enkephalin-degrading enzymes (PMID: 12942748)
Summary
Livagen and Epitalon affected enkephalin-degrading enzyme activity in human serum, pointing to regulatory effects on peptidase systems.
Relevance
Supplementary mechanistic evidence for Livagen.
See Also
- Parent compound: Livagen
Where to buy Livagen
Livagen4 vetted vendors
BioLongevity LabsVisit BioLongevity Labs →
Save 15% with code VIALBASE
VialBase may earn a commission on partner links — never at extra cost to you. Disclosure.